Merz declares, to the best of its knowledge and based on its good faith understanding of the statutory requirements, that it is in compliance with its CCP and the requirements of the California Health and Safety Code § 119402 as of August 14, 2017. Merz will evaluate and update its CCP, as necessary and appropriate.
A copy of Merz’s CCP may be obtained by emailing us at firstname.lastname@example.org or by calling 1-888-924-4269.
Merz has developed and adopted a Comprehensive Compliance Program (CCP) in accordance with the Compliance Program Guidance for Pharmaceutical Manufacturers published by the Office of Inspector General of the US Department of Health and Human Services (OIG Guidance) and incorporates policies that comply with the Pharmaceutical Research and Manufacturers of America’s Code on Interactions with Healthcare Professionals (PhRMA Code) as revised from time to time. Merz intends for this program, in conjunction with its California Compliance Policy, to meet the requirements of the State of California as well as other states that have enacted laws requiring pharmaceutical companies to implement a comprehensive compliance program and code of conduct.